Despite several studies support a positive association between heavy alcohol consumption and liver cancer risk, a consistent dose-risk relationship has not yet been established. We carried out a systematic review and a meta-analysis of the association between alcohol intake and liver cancer occurrence, following the Meta-analysis Of Observational Studies in Epidemiology guidelines. We searched for cohort and nested case-control studies on the general population published before April 2013, using PubMed and EMBASE. Summary meta-analytic relative risks (RRs) were estimated using random-effect models. We included 16 articles (19 cohorts) for a total of 4445 incident cases and 5550 deaths from liver cancer. Compared with non-drinking, the pooled RRs were 0.91 (95% confidence interval, CI, 0.81-1.02) for moderate drinking (<3 drinks per day) and 1.16 (95% CI, 1.01-1.34) for heavy drinking (≥3 drinks per day), with significant heterogeneity among studies. The dose-risk curve suggested a linear relationship with increasing alcohol intake in drinkers, with estimated excess risk of 46% for 50 g of ethanol per day and 66% for 100 g per day. This systematic review suggests a moderate detrimental role of consumption of 3 or more alcoholic drinks per day on liver cancer, and a lack of association with moderate drinking. Our results have to be taken with due caution on account of the possible limitations of the original studies included in the meta-analysis.
introduction Worldwide, the major risk factors for hepatocellular carcinoma (HCC), the most frequent histological type of primary liver cancer, are persistent infection with hepatitis B virus (HBV) and hepatitis C virus (HCV), both of which increase the risk of liver cancer some 20-fold [1] . Other established risk factors include non-alcoholic fatty liver disease, tobacco smoking, exposure to aflatoxine-contaminated food, and some rare inherited disorders, including hereditary hemochromatosis [2] . Most, but not all, HCCs occur in cirrhotic livers, and cirrhosis is a pathogenic step in liver carcinogenesis [3] . In alcoholics, prolonged, excessive alcohol consumption results in alcoholic cirrhosis. Moreover, alcohol may enhance and/or accelerate hepatocarcinogenesis in patients with HBV and/or HCV infection, hereditary hemochromatosis, or non-alcoholic fatty liver disease [4] .
Alcohol has been associated with increased risk of primary liver cancer [5, 6] , although not as strongly as for cancers of the upper aerodigestive tract [5] . Thereby, despite the high number of studies supporting an association between heavy alcohol consumption and liver cancer, a consistent dose-risk relationship has not yet been established. Moreover, most of the evidence is based on case-control studies, in which the association is likely to be underestimated, as most alcohol-related liver cancers follow liver diseases-and in particular cirrhosis-which leads to a reduction in alcohol drinking [3] .
Therefore, we systematically reviewed prospective studies and quantitatively assessed the association between alcohol intake and liver cancer risk. Only studies with a prospective design, in which alcohol consumption was assessed at baseline, i.e. before liver cancer occurrence, were included, in order to avoid bias caused by alcohol cessation/reduction following clinical symptoms.
materials and methods

search strategy and data collection
In this meta-analysis, we followed the guidelines for reporting developed by the Meta-analysis Of Observational Studies in Epidemiology group [7] . In April 2013, two authors (FT and CG) carried out a systematic literature search in the Medline database, using PubMed, and in EMBASE for all prospective studies investigating the association between alcohol and liver cancer incidence or mortality.
Because the nested case-control study in a prospective cohort is just an efficient sampling of the same cohort study and thus retains the same prospective advantages of the cohort, including the fact that dietary information was collected among apparently healthy participants at baseline before the development of the outcome of interest, we also searched for nested case-control studies. We used the following search string in PubMed: (alcohol OR ethanol) AND (liver OR hepatocellular) AND (cancer OR neoplasm OR carcinoma) AND (cohort OR cohort studies[MeSH Terms] OR prospective). A similar strategy was used to search Embase. The searches were limited to studies written in English.
The same authors retrieved and assessed potentially relevant articles; abstracts and unpublished studies were not included. No studies were excluded a priori for weakness of design or data quality. Each publication identified was reviewed and included in the analysis if the following criteria were met: cohort or nested case-control study conducted on the general population, considering at least three levels of alcohol consumption, and reporting the estimates of the relative risk (RR)/odds ratio/ hazard ratio for primary liver cancer or HCC and the corresponding confidence interval (CI)-or information sufficient to calculate them-for each exposure level. Studies on special populations (e.g. cohorts of cirrhotic patients, patients HBV/ HCV infected, or alcoholics), studies considering liver cholangiocarcinoma [8] , studies analyzing alcohol consumption by combining in a unique variable information on dose and duration (e.g. cumulative lifetime alcohol intake) [9] , or studies that met the inclusion criteria but reported information only on specific types of alcoholic beverages [10, 11] were not included. One nested case-control study reporting odds ratios for HCC mortality according to tertiles of consumption, without providing category boundaries was also excluded [12] . When multiple reports were published on the same study population, we included in the meta-analysis only the most informative one. In particular, we included a pooled analysis of four Japanese cohorts [13] , rather than separate publications from the single studies, since one of these cohorts did not publish results on alcohol. By checking the reference list of all papers of interest, we identified three additional publications [14] [15] [16] .
Two of the authors (FT and MR) independently reviewed all the studies and abstracted the following information in a standard format: study design, country, period of enrolment and/or follow-up, number of subjects (cases, controls or non-cases or cohort size), gender, covariates adjusted for in the analysis, RR estimates (odds ratios or RRs or hazard ratios, collectively referred to as RRs) for categories of alcohol consumption and the corresponding 95% CIs, and, when available, the number of cases and non-cases for each level of alcohol consumption considered.
statistical analysis
In the analyses on amount of alcohol drinking, we used the midpoint of each category of alcohol consumption for each study.
For upper, open-ended exposure categories, we used 1.2-fold its lower bound [17] . Grams of ethanol were used as measure for the analyses, defining one drink as 12.5 g of ethanol, if not otherwise specified in the original report, and 1 ml as 0.79 g of ethanol. We used the lowest category of exposure in each study (mostly, non-drinking) as reference category (i.e. non-drinking, hereafter). When original reports provided RRs using a different reference category (e.g. moderate drinking), the new RRs were calculated dividing each RR by the RR for non-drinking, and the corresponding CIs were calculated using the standard errors of the corresponding crude RR estimates, penalized by a factor of 1.5 [13, 16] . One study using moderate drinking as reference category which did not provide information sufficient for estimating CIs for different alcohol doses when compared with non-drinking was not included [18] . In the Million Women Study [19] and in a cohort study from China [20] , we derived the floated variances from the 95% floated CIs provided by the authors, to obtain RRs and 95% CIs for different categories of alcohol consumption compared with non-drinking [21] . In a study reporting multivariate RRs but not the corresponding CIs [15] , the standard error of the adjusted estimate was obtained by penalizing the standard error of the crude RR by a factor of 1.5. We summarized decisions and operations on original data for each study in the column 'notes' of Table 1 .
We defined moderate alcohol drinking as <3 drinks per day, i. e. <37.5 g of ethanol per day, and heavy drinking as ≥3 drinks per day. When more than one estimate in a study fell in the range considered for moderate or heavy drinking, we pooled the corresponding estimates using, whenever possible, the Hamling et al. method [22] , thus taking into account their correlation. Otherwise, we used fixed-effects models.
We calculated summary estimates of the RR using randomeffects models [i.e. as weighed averages using the inverse of the sum of the variance of the log(RR) and the moment estimator of the variance between studies as weight] [23] . Heterogeneity between studies was assessed using the χ 2 test, defined as a P < 0.10, and inconsistency was measured using also the I 2 statistic [24] . We conducted sensitivity analyses by excluding each study at a time from the meta-analysis. In order to investigate possible sources of heterogeneity among studies, we also conducted subgroups analyses according to potentially relevant factors.
For the dose-response analysis, we used a random-effect meta-regression model in a non-linear dose-response relationship framework, providing the best fitting two-term fractionalpolynomial model [25] . The presence of publication bias was assessed by examination of funnel plot [26] and by applying the tests proposed by Begg and Mazumdar [27] , and by Egger et al. [28] . All the statistical analyses were carried out using the STATA software (version 11; StataCorp, College Station, TX).
results
The present meta-analysis included 16 publications (19 cohorts): 5 publications gave results from nested case-control studies [14, 15, [29] [30] [31] , 10 from cohort studies [16, 19, 20, [32] [33] [34] [35] [36] [37] [38] , and 1 from a pooled analysis of 4 cohorts [13] , for a total of 4445 incident cases and 5550 deaths from liver cancer ( Table 1) . Fifteen cohorts were from Asia, two from Europe, and one from the United States; one cohort from Hawaii (United States) included men of Japanese ancestry. There was no significant publication bias for both the moderate (P for Begg and Mazumdar's test = 0.496, P for Egger's test = 0.995) and the heavy drinking analyses (P for Begg and Mazumdar's test = 0.161, P for Egger's test = 0.101). Figure 1 shows the study-specific and pooled RRs and 95% CIs of liver cancer for moderate drinking, i.e. <3 drinks per day, versus non-drinking. Based on 16 studies, the pooled RR was 0.91 (95% CI, 0.81-1.02), similar between cohort and nested case-control studies, with significant heterogeneity among studies (P < 0.001, I 2 = 65.6%). Figure 2 shows the study-specific and pooled RRs and 95% CIs of liver cancer for heavy drinking, i.e. ≥3 drinks per day, versus non-drinking. Ten RR estimates were above unity (significant in 6 studies) and three were below unity (non significant), resulting in a pooled RR of 1.16 (95% CI, 1.01-1.34), based on 13 studies. There was significant heterogeneity among studies (P = 0.002, I 2 = 60.5%). The pooled RRs were 1.08 (95% CI, 0.98-1.19) for cohort (P for heterogeneity = 0.123, I 2 = 38.4%) and 2.63 (95% CI, 1.62-4.28) for nested case-control studies (P for heterogeneity = 0.359, I 2 = 8.3%). The exclusion of each study in turn did not materially change the pointwise estimate of the RR. However, statistical significance was lost after the exclusion, in turn, of 6 [14, 20, 29, 30, 35, 37] of the 13 studies from the meta-analysis. When heavy drinking was defined as ≥6 drinks per day, i.e. ≥75 g of ethanol per day, the pooled RR from six studies was 1.22 (95% CI, 1.10-1.35), with no significant heterogeneity (P = 0.786, I 2 = 0%). Table 2 gives the pooled RRs and 95% CIs of liver cancer at different levels of alcohol drinking in strata of selected factors. Results for moderate and heavy drinking were not materially different in strata of sex, geographic area, and outcome. Considering adjustment for hepatitis, very similar RRs were found for moderate drinking, while, for heavy drinking, an RR of 1.25 (95% CI, 1.01-1.55) was estimated from studies not adjusting for hepatitis and an RR of 1.08 (95% CI, 0.88-1.33) from those adjusting for hepatitis. Figure 3 gives the dose-risk curve and the 95% pointwise confidence bands for the relation between alcohol consumption and cancer of the liver. Among the two terms fractional-polynomial models, the linear regression represented the best-fitting Including one study carried out in Hawaii on men of Japanese ancestry [34] . b Including one study adjusting for chronic conditions [38] . Figure 2 . Forest plot for study-specific and pooled RRs and 95% CIs of liver cancer for heavy alcohol drinking (≥3 drinks per day) versus non-drinking. dose-response relationship, leading to pooled RR estimates of 1.06 (95% CI, 1.02-1.11) for 12 g, 1.13 (95% CI, 1.04-1.24) for 25 g, 1.29 (95% CI, 1.08-1.53) for 50 g, 1.46 (95% CI, 1.13-1.89) for 75 g, and 1.66 (95% CI, 1.17-2.34) for 100 g of ethanol per day.
discussion
This meta-analysis of 19 cohorts, including a total of 4445 incident cases and 5550 deaths from liver cancer, found a significant 16% increased risk of liver cancer among alcohol drinkers of 3 or more drinks per day, compared with non-drinkers. Evidence of a positive association between heavy alcohol drinking and liver cancer derived mainly from nested case-control studies. The increased risk for those drinking 6 or more drinks per day, compared with non-drinkers, was 22%. Moderate drinkers (i.e. drinkers of <3 drinks per day) were not at increased risk of liver cancer. The dose-risk curve suggested a linear relationship with increasing alcohol intake in drinkers, with estimated excess risk of 46% for 50 g of ethanol per day and 66% for 100 g per day, and points to a possible strong detrimental effect of even higher doses of alcohol. However, quantitative data provided from original studies included in this meta-analysis did not allow us to provide reliable meta-analytic RR estimates for such elevated alcohol doses. A detrimental role of extremely high alcohol doses has been suggested by studies on alcoholics and cirrhotic subjects, which globally showed evidence of a strong association between alcoholism, cirrhosis, and liver cancer [39] [40] [41] [42] [43] . Indeed, in alcoholics, prolonged, excessive alcohol consumption results in alcoholic cirrhosis, which is a pathogenic step in liver carcinogenesis [3] .
In addition to the carcinogenicity of acetaldehyde, which is the first metabolite of alcohol [6] , several potential biologic mechanisms have been proposed to explain the effect of alcohol on hepatocarcinogenesis. These include chronic inflammation, resulting in increased oxidative stress, induction of cytochrome P-450 2E1, leading to increased reactive oxygen species production, lipid peroxidation and DNA damage, a decrease in antioxidant defense and DNA repair, disturbed methyltransfer associated with DNA hypomethylation, decreased hepatic retinoic acid, iron overload, and impairment of the immune system [4] .
An earlier meta-analysis of epidemiological studies on the association between alcohol drinking and the risk of cancer at several sites included data from 17 case-control and 3 cohort studies on liver cancer, for a total of 2294 cases [5] . The RR estimates were 1.17 (95% CI, 1.11-1.23), 1.36 (95% CI, 1.23-1.51), and 1.86 (95% CI, 1.53-2.27) for 25, 50, and 100 g of ethanol per day, respectively. A more recent meta-analysis, assessing the risk for light drinking only and including 7 cohort and 13 casecontrol studies, gave a RR of 1.03 (95% CI, 0.90-1.17) [44] . A review of the Chinese literature investigating the role of alcohol on several cancers pooled results from 18 case-control studies on HCC and found a summary odds ratio of 1.56 (95% CI, 1.16-2.09) for any drinking versus non-drinking [45] . No information on the dose-risk relationship was provided. A systematic review on alcohol drinking and liver cancer risk among the Japanese population identified 22 cohort and 24 case-control studies [46] . On the basis of those studies, authors concluded that there is convincing evidence that alcohol drinking increases the risk of primary liver cancer. However, the association was not quantified.
A possible explanation for the relatively modest effect of alcohol on liver cancer occurrence is that at least part of the cohorts might have included subjects with chronic liver diseases at baseline. Those subjects are at increased liver cancer risk due to their liver condition, and are likely to have stopped drinking or to have reduced alcohol consumption due to symptoms of the disease or advice from a physician. This would lead to underestimation of the association between alcohol and liver cancer. This may be particularly relevant since most of the studies were conducted in Asia, where the prevalence of HBV is high [47] . However, the association was, if anything, smaller when the analyses were restricted to non-Asian countries. Careful allowance for hepatitis, in addition, did not explain the association between alcohol and liver cancer risk in a case-control study with thirdgeneration enzyme immunoassay [48] .
Cohort studies may also underestimate the real association if a considerable proportion of the cohort stops exposure during follow-up. This is a major issue in the analysis of smoking and myocardial infarction whenever part of the cohort stops smoking [49] . However, after stopping exposure, the risk of cancer declines over considerably longer time than the risk of infarction, and in particular the time-risk relation after stopping alcohol drinking gives clear evidence of falls in risk of cancer only after 20 years [50] [51] [52] [53] .
Among the limitations, significant heterogeneity was detected across studies. Therefore, even if we used random-effects models to take heterogeneity into account, our pooled estimates should be interpreted with caution. A limitation of the dose-risk analysis is that it assumes a dose-response effect with no threshold. Since the slope of the function depends on the level of misclassification in the different categories of alcohol consumption, if heavy drinking is more frequently misclassified than drinking at lower doses, the slope of the dose-risk function at low doses will be over-estimated [25] .
It is possible that alcohol consumption is systematically underreported in several studies. This would lead to systematic underestimation of any real association. However, studies investigating reproducibility and validity of self-reported alcohol drinking in various populations found satisfactory correlation coefficients [54] [55] [56] [57] . Another problem regarding misclassification is the inclusion of former drinkers in the non-drinkers reference category, thus leading to possible underestimation of the risk of current drinkers. Indeed, among the 16 studies included, only two [14, 29] investigated lifetime alcohol consumption, separating never from former drinkers. However, we included only studies with a prospective design, which should be less affected by this problem than those with a retrospective design, since in prospective studies, information is collected among (apparently) healthy participants before the onset of symptoms.
An increased liver cancer risk has been consistently associated with tobacco smoking [31, 58] , which usually correlates positively with alcohol drinking. Moreover, liver cancer risk was found to be increased among overweight and obese subjects [59, 60] . The relation between alcohol drinking and body mass index is complex [61] [62] [63] [64] , but heavy drinkers tend to have lower body mass index, if anything, due to their frequent poor nutrition. Therefore, whenever available, we included multivariate RRs adjusted for tobacco and overweight/obesity. However, some role of residual confounding cannot be excluded.
We could not investigate the role of different drinking patterns as well as of smoking in modifying the effect of the total amount of alcohol consumed, since only a limited number of studies provided details on these issues.
The major strengths of our meta-analysis were the collection of a uniquely large number of liver cancer cases or deaths, which enabled us to explore in detail the association of interest among selected subgroups, and the use of a systematic meta-analytic approach to summarize our results. Moreover, the funnel plot and the Begg and Mazumdar's and Egger's tests for funnel plot asymmetry did not support the presence of major publication bias, providing further indication of the robustness of our findings.
In conclusion, this meta-analysis suggests a moderate detrimental role of consumption of 3 or more alcoholic drinks per day, compared with no alcohol consumption, on liver cancer risk. Caution is however required in interpreting the present results because of the possible limitations of the original studies included in the meta-analysis, despite the restriction of our analyses to studies with a prospective design. These limitations include mainly underestimation of drinking, reverse causation (i.e. inclusion of subjects with liver diseases at baseline), and changes in drinking habits over time. 
